Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia

Neuropsychopharmacology

Volumn 20, Issue 2, 1999, Pages 131-140

  Cecil, Kim M ^a   Lenkinski, Robert E ^a   Gur, Raquel E ^a   Gur, Ruben C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Proton magnetic resonance spectroscopy; Schizophrenia

Indexed keywords

AMINO ACID; CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; TEMPORAL LOBE;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN CHEMISTRY; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 0033080739     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00063-3     Document Type: Article

References (52)

1. Andreasen N.C., Ehrhardt J.C., Swayze V.W.2d, Alliger R.J., Yuh W.T., Cohen G., Ziebell S. Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities. Arch Gen Psychiatr. 47:1990;35-44.
2. Arnold S.E., Franz B.R., Gur R.C., Gur R.E., Shapiro R.M., Moberg P.J., Trojanowski J.Q. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatr. 152:1995;738-748.
3. Arnold S.E., Hyman B.T., Van Hoesen G.W., Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatr. 48:1991;625-632.
4. Barta P.E., Pearlson G.D., Powers R.E., Richards S.S., Tune L.E. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatr. 147:1990;1457-1462.
5. 1H nmr spectra of human brain. Mag Res Med. 32:1994;294-302.
6. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T.W., Frank J.A., Tedeschi G., Weinberger D.R. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatr. 153:1996;1554-1563.
7. 1H-NMR spectroscopic studies of brain Neurosci Biobehav Rev. 13:1989;23-31.
8. Bogerts B., Falkai P., Haupts M., Greve B., Ernst S., Tapernon-Franz U., Heinzmann U. Postmortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection Schiz Res. 3:1990;295-301.
9. Brand A., Richter-Landsberg C., Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci. 15:1993;289-298.
10. Breier A., Buchanan R.W., Elkashef A., Munson R.C., Kirkpatric B., Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures Arch Gen Psychiatr. 49:1992;921-926.
11. Brown R., Colter N., Corsellis J.A.N. Postmortem evidence of structural changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affected disorder Arch Gen Psychiatr. 43:1986;36-42.
12. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia. Clinical, neurodevelopmental, and cognitive correlates Biol Psychiatr. 36:1994;792-800.
13. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biol Psychiatr. 32:1992;26-32.
14. 1H Magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia. Acad Radiol. 1:1994;211-216.
15. Cohen B.M., Renshaw P.F., Stoll A.L., Wurtman R.J., Yurgelun-Todd D., Babb S.M. Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study JAMA. 274:1995;902-907.
16. Cowell P.E., Turetsky B.I., Gur R.C., Grossman R.I., Shtasel D.L., Gur R.E. Sex differences in aging of the human frontal and temporal lobes. J Neurosci. 14:1994;4748-4755.
17. Coyle J.T. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatr. 3:1996;241-253.
18. Deicken R.F., Calabrese G., Merrin E.L., Fein G., Weiner M.W. Basal ganglia phosphorous metabolism in chronic schizophrenia. Am J Psychiatr. 152:1995;126-129.
19. 1H spectroscopy of major brain metabolites. Magn Res Med. 21:1991;82-96.
20. Feinberg I. Schizophrenia. Caused by a fault in programmed synaptic elimination in adolescence? J Psychiatr Res. 17:1982;319-334.
21. Fukuzako H., Takeuchi K., Hokazono Y., Fukuzako T., Yamada K., Hashiguchi T., Obo Y., Ueyama K., Takigawa M., Fujimoto T. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia. preliminary report Psychiatr Res. 61:1995;193-200.
22. Gur R.E., Jaggi J.L., Shtasel D.L., Ragland J.D., Gur R.C. Cerebral blood flow in schizophrenia. Effects of memory processing on regional activation Biol Psychiatr. 35:1994;3-15.
23. Gur R.E., Mozley P.D., Resnick S.M., Levick S., Erwin R., Saykin A.J., Gur R.C. Relations among clinical scales in schizophrenia. Am J Psychiatr. 148:1991;472-478.
24. Gur R.E., Mozley P.D., Resnick S.M., Mozley L.H., Shtasel D.L., Gallacher F., Arnold S.E., Karp J.S., Alavi A., Reivich M., Gur R.C. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Arch Gen Psychiatr. 52:1995;657-667.
25. Gur R.E., Pearlson G.D. Neuroimaging in schizophrenia research. Schiz Bull. 19:1993;337-353.
26. Huttenlocher P.R. Synaptic density in human frontal cortex. Developmental changes and effects of aging Brain Res. 163:1979;195-205.
27. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia. A morphometric study Arch Gen Psychiatr. 46:1985;1019-1024.
28. Keshavan M.S., Pettegrew J.W., Panchalingam K.S., Kaplan D., Bozik E. Phosphorus-31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia [letter]. Arch Gen Psychiatr. 48:1991;1112-1113.
29. 31P MRS and MRI studies Schiz Res. 10:1993;241-246.
30. Kotrla K.J., Weinberger D.R. Brain imaging in schizophrenia. Ann Rev Med. 46:1995;113-122.
31. Lieberman J., Bogerts B., Degreef G., Ashtari M., Lantos G., Alvir J. Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatr. 149:1992;784-794.
32. Michels K.B., Rosner B.A. Data trawling. To fish or not to fish Lancet. 348:1996;1152-1153.
33. 1H MRS) of the hippocampal formation in schizophrenia. A pilot study Br J Psychiatr. 165:1994;481-485.
34. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatr. 3:1995;241-253.
35. 31P nuclear magnetic resonance spectroscopy. Neurodevelopment and schizophrenia Schiz Bull. 19:1993;35-53.
36. 31P MRS of metabolic alterations in schizophrenia and neurodevelopment. Nasrallah H.A., Pettegrew J.W. NMR Spectroscopy in Psychiatric Brain Disorders. 1995;American Psychiatric Press, Washington, DC.
37. Pettegrew J.W., Keshavan M.S., Panchalingam K., Strychor S., Kaplan D.B., Tretta M.G., Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy [see comments]. Arch Gen Psychiatr. 48:1991;563-568.
38. Radda G.K., Taylor D.J. Applications of nuclear magnetic resonance spectroscopy in pathology. Int Rev Exp Path. 27:1985;58.
39. Renshaw P.F., Yurgelun-Todd D.A., Tohen M., Gruber S., Cohen B.M. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatr. 152:1995;444-446.
40. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology. 1:1990;43-46.
41. Shenton M.E., Kikinis R., Jolesz F.A. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study N Engl J Med. 327:1992;604-612.
42. Shioiri T., Kato T., Inubushi T., Murashita J., Takahashi S. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatr Res. 55:1994;223-235.
43. Spitzer RL, Williams JBW, Gibbon M (1994a): Structured Clinical Interview for DSM-IV-Patient Version (SCID-P). New York, New York State Psychiatric Institute.
44. Spitzer RL, Williams JBW, Gibbon M (1994b): Structured clinical interview for DSM-IV: Nonpatient version (SCID-NP). New York, New York State Psychiatric Institute.
45. Stanley J.A., Drost D.J., Williamson P.C., Carr T.J. In vivo proton MRS study of glutamate in schizophrenia. Nasrallah H.A., Pettegrew J.W. NMR Spectroscopy in Psychiatric Brain Disorders, vol 47. 1995;21-44 American Psychiatric Press, Washington, DC. a.
46. Stanley J.A., Williamson P.C., Drost D.J., Carr T.J., Rylett R.J., Malla A., Thompson R.T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatr. 52:1995;399-406. b.
47. Stanley J.A., Williamson P.C., Drost D.J., Carr T.J., Rylett R.J., Morrison-Stewart S., Thompson R.T. Membrane phospholipid metabolism and schizophrenia. An in vivo 31P-MR spectroscopy study Schiz Res. 13:1994;209-215.
48. Stanley J.A., Williamson P.C., Drost D.J., Rylett R.J., Carr T.J., Malla A., Thompson R.T. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schiz Bull. 22:1996;597-609.
49. Suddath R.L., Casanova M.F., Goldberg T.E., Daniel D.G., Kelsoe J.R. Jr., Weinberger D.R. Temporal lobe pathology in schizophrenia. A quantitative magnetic resonance imaging study Am J Psychiatr. 146:1989;464-472.
50. Turetsky B., Cowell P.E., Gur R.C., Grossman R.I., Shtasel D.L., Gur R.E. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. Arch Gen Psychiatr. 52:1995;1061-1070.
51. Yurgelun-Todd D.A., Renshaw P.F., Gruber S.A., Waternaux C., Cohen B.M. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schiz Res. 19:1996;55-59.
52. 1H MRS of N-acetyl aspartate (NAA) in temporal lobes of schizophrenia. Biol Psychiatr. 133:1993;45.